4.5 Article

Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 -, 期 -, 页码 -

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.2c00073

关键词

fluorescent tracer; soluble epoxide hydrolase; NanoBRET; assay development

资金

  1. Alzheimer Forschung Initiative project [20041]
  2. Buchmann Fellowship
  3. Deutsche Forschungsgemeinschaft (DFG) [HI 2351/1-1, PR 1405/7-1, PR 1405/8-1, SFB 1039 TP A07, HE 6867/3-1]

向作者/读者索取更多资源

In this study, a small fluorescent sEH inhibitor was designed and showed excellent potency in vitro and the ability to visualize sEH in living cells.
Soluble epoxide hydrolase (sEH) is a promising target for a number of inflammation-related diseases. In addition, inhibition of sEH has been shown to reduce neuroinflammation, which plays a critical role in the development of central nervous system (CNS) diseases such as Alzheimer's disease. In this study, we present the rational design of a small fluorescent sEH inhibitor. Starting from the clinical candidate GSK2256294A, we replaced the triazine moiety with the 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-CI) fluorophore. The resulting fluorescent sEH inhibitor displayed excellent potency in an in vitro enzyme activity assay (IC50 < 2 nM). The developed inhibitor is applicable in a NanoBRET-based assay system suitable for studying sEH target engagement in living cells. Furthermore, the inhibitor can be used to visualize sEH in sEH-transfected HEK293 cells and in primary mouse astrocytes by fluorescence microscopy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Compilation and evaluation of a fatty acid mimetics screening library

Johanna H. M. Ehrler, Steffen Brunst, Amelie Tjaden, Whitney Kilu, Jan Heering, Victor Hernandez-Olmos, Andre Krommes, Jan S. Kramer, Dieter Steinhilber, Manfred Schubert-Zsilavecz, Susanne Muller, Daniel Merk, Ewgenij Proschak

Summary: This study presents the compilation and application of a focused screening library of fatty acid mimetics (FAMs), which are designed to bind proteins that accommodate natural fatty acids and lipid metabolites. Several hits were retrieved in screening the focused library against various fatty acid binding targets.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2and TAZ-signaling

Luisa D. Burgers, Yanfen Li, Stylianos Michalakis, Sarah Ciurus, Stefan Zahler, Rolf Mueller, Robert Fuerst

Summary: This study provides evidence that vioprolide A (vioA) is an interesting compound with anti-angiogenic and anti-inflammatory effects. VioA reduced angiogenic features in endothelial cells by decreasing VEGFR2 protein levels and TAZ signaling. Surprisingly, vioA also promoted cell survival by activating Akt and inhibiting apoptosis. Further preclinical studies on vioA are warranted based on these findings.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Biochemistry & Molecular Biology

Detailed Characterization of Small Extracellular Vesicles from Different Cell Types Based on Tetraspanin Composition by ExoView R100 Platform

Kai Breitwieser, Leon F. Koch, Tobias Tertel, Eva Proestler, Luisa D. Burgers, Christoph Lipps, James Adjaye, Robert Fuerst, Bernd Giebel, Meike J. Saul

Summary: Small extracellular vesicles (sEV) show great potential as biomarkers, drug carriers, and therapeutics. However, limited phenotypic characterization of sEV at the single vesicle level has resulted in sparse knowledge of cell type-specific sEV signatures. With the introduction of next-generation sEV analysis devices, such as the ExoView R100 platform, single sEV analyses are now possible, leading to a better understanding of the complexity and heterogeneity of sEV. The study demonstrates that tetraspanin composition in sEV varies among different cell types and can be influenced by cell culture conditions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Human 5-lipoxygenase regulates transcription by association to euchromatin

Marius Kreiss, Julia H. Oberlis, Sabine Seuter, Iris Bischoff-Kont, Duran Sueruen, Dominique Thomas, Tamara Goebel, Tobias Schmid, Olof Radmark, Ralf P. Brandes, Robert Fuerst, Ann-Kathrin Haefner, Dieter Steinhilber

Summary: This study reveals a noncanonical function of 5-LO as a transcriptional regulator in monocytic cells. Through gene knockout and RNA-Seq analysis, the study identifies 5-LO regulated genes and shows its effects on cell adhesion and tryptophan metabolism.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Food Science & Technology

The Pharmacological Potential of Novel Melittin Variants from the Honeybee and Solitary Bees against Inflammation and Cancer

Pelin Erkoc, Bjoern Marcus von Reumont, Tim Lueddecke, Marina Henke, Thomas Ulshoefer, Andreas Vilcinskas, Robert Fuerst, Susanne Schiffmann

Summary: The venom of honeybees, specifically melittin peptides, has shown potential therapeutic effects on inflammation and cancer. This study explores the pharmacological activities of known and newly discovered melittin variants from honeybees and older solitary bees in the context of cancer and inflammation. The findings suggest that some ancestral variants from solitary bees have promising therapeutic potential in modulating inflammatory processes and inhibiting cancer cell viability/proliferation, including aggressive breast cancers.

TOXINS (2022)

Review Chemistry, Multidisciplinary

Preparative Scale Applications of C-H Activation in Medicinal Chemistry

Rita de Jesus, Kerstin Hiesinger, Manuel van Gemmeren

Summary: C-H activation is a promising method for increasing molecular complexity in drug synthesis. Despite facing challenges at a large scale, its advantages in shorter synthetic routes and simpler starting materials motivate chemists to explore its potential in pharmaceutical production. This review covers examples of drugs/drug candidates where C-H activation has been implemented on a preparative synthetic scale, analyzing the optimization processes and advantages and disadvantages for a comprehensive understanding of its challenges and potential in drug synthesis.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Biochemistry & Molecular Biology

Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors

Marco J. J. Rotter, Sabrina Zentgraf, Lilia Weizel, Denia Frank, Luisa D. Burgers, Steffen Brunst, Robert Fuerst, Anna Proschak, Thomas A. Wichelhaus, Ewgenij Proschak

Summary: Metallo beta lactamases (MBLs) have become a major problem in treating multidrug-resistant Gram-negative pathogens due to their ability to resist a broad range of drugs and lack of effective inhibitors. In this study, we designed catechol-containing MBL inhibitors that mimic bacterial siderophores, which are actively taken up by bacteria through their iron acquisition system. The most potent catechol-containing MBL inhibitor demonstrated binding to Fe3+ ions and restored the effectiveness of imipenem in NDM-1-expressing K. pneumoniae without affecting healthy cells. These siderophore-containing MBL inhibitors could be a promising strategy to combat MBL-mediated resistance to beta lactam antibiotics.

MOLECULES (2023)

Article Cell Biology

The Microtubule-Targeting Agent Pretubulysin Impairs the Inflammatory Response in Endothelial Cells by a JNK-Dependent Deregulation of the Histone Acetyltransferase Brd4

Tobias F. Primke, Rebecca Ingelfinger, Mohammed A. F. Elewa, Igor Macinkovic, Andreas Weigert, Matthias P. Fabritius, Christoph A. Reichel, Angelika Ullrich, Uli Kazmaier, Luisa D. Burgers, Robert Fuerst

Summary: Research has found that depolymerizing microtubule-targeting agents can reduce inflammation by inhibiting the expression of pro-inflammatory molecules and decreasing leukocyte adhesion to endothelial cells. These agents not only affect leukocytes but also significantly decrease the inflammatory response of vascular endothelial cells. The study sets a baseline for further exploration of the anti-inflammatory effects of depolymerizing microtubule-targeting agents.
Article Biochemistry & Molecular Biology

Venomics of the milos viper (Macrovipera schweizeri) unveils patterns of venom composition and exochemistry across blunt-nosed viper venoms

Lennart Schulte, Maik Damm, Ignazio Avella, Lilien Uhrig, Pelin Erkoc, Susanne Schiffmann, Robert Fuerst, Thomas Timm, Guenter Lochnit, Andreas Vilcinskas, Tim Lueddecke

Summary: Snakebite is an neglected tropical disease and the Vipers of the genus Macrovipera are medically important snakes in the Old World. This study presents the first proteomic evaluation of the venom from a Greek endemic Milos viper, revealing the presence of coagulotoxic and cytotoxic protein families. The research highlights the importance of further comparative studies across the genus Macrovipera for optimized treatment of envenomations.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Meeting Abstract Pharmacology & Pharmacy

First preclinical insights into the anti-angiogenic actions of C81

T. Zech, I. Bischoff-Kont, G. M. Krishnathas, L. Berger, S. Roesser, B. Stroedke, T. Schmid, S. Mueller, S. Knapp, F. Bracher, R. Fuerst

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

Meeting Abstract Pharmacology & Pharmacy

The microtubule-targeting agent pretubulysin impairs inflammatory key features in endothelial cells in vitro and in vivo

T. Primke, R. Ingelfinger, M. Fabritius, C. Reichel, A. Ullrich, U. Kazmaier, R. Fuerst

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

暂无数据